Brandon Pierce and Chenan Zhang take a look at how smoking affects telomeres–protective caps on our DNA–and what that means for health.
University of Chicago scientists are forging unexpected collaborations in a quest to understand and harness the capability of microbes.
After nearly two decades of unsuccessful attempts, researchers from the University of Chicago Medicine and the Cincinnati Children’s Hospital Medical Center have created the first mouse model for acute lymphoblastic leukemia.
Many cancer patients respond favorably to immunotherapies, but most do not. Two new studies by UChicago cancer specialists in PNAS try to find out why.
Susan G. Komen, one of the nation’s leading breast cancer organizations, recently awarded the UChicago Comprehensive Cancer Center a three-year, $405,000 grant to establish a graduate training program to study the causes of breast cancer disparities.
Tumor cells collected during the removal of a cancerous bladder could help physicians identify high-risk cancers and personalize care, according to a new study by UChicago’s Ralph Weichselbaum.
Government, academic, pharmaceutical and diagnostic companies have agreed to jump-start the development of an open database for cancer data using the NCI Genomic Data Commons at UChicago.
A team of cancer specialists and health economists have developed a tool that can measure a patient’s risk for, and ability to tolerate, the financial stress associated with treatment.
A renowned biostatistician and epidemiologist who used those tools to study cancer risk, prevention and treatment and the impact of environmental exposures on health, John C. Bailar, professor emeritus in the Department of Public Health Sciences at the University of Chicago, died Sept. 6. He was 83.
Wenbin Lin and his lab are combining nanoscale metal frameworks with photosensitive molecules to deliver immunotherapy drugs to treat cancer.